Biosimilars and Biobetters

Latest News

row of medical bottles | Image Credit: ©petrovk – stock.adobe.com
The Challenge of Market Uptake for Biosimilars

May 7th 2025

As more originator biologics lose patent exclusivity in the next decade, a healthy biosimilars pipeline is necessary but requires market support.

High Angle Shot of a Working Desk of an Successful Person in Office with Cityscape Window View. | Image credit: © Gorodenkoff - stock.adobe.com
Reimagining Progress: Partnering for the Future of Bio/Pharma

May 1st 2025

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
Celltrion’s YUFLYMA (adalimumab-aaty) Receives FDA Interchangeable Designation as Biosimilar to Humira (adalimumab)

April 17th 2025

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
Teva and Samsung Bioepis Launch Biosimilar Eculizumab in US Market

April 17th 2025

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
EMA Proposes Ways to Improve Development and Evaluation of Biosimilars

April 8th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.